These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32221151)

  • 1. Safety and efficacy data supporting U.S. FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management.
    Wilson ME; Trivedi RH; Plager DA
    J Cataract Refract Surg; 2020 Jun; 46(6):873-878. PubMed ID: 32221151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: Integrated results from 2 pivotal phase 3 studies.
    Hovanesian JA; Sheppard JD; Trattler WB; Gayton JL; Malhotra RP; Schaaf DT; Ng E; Dunn SH
    J Cataract Refract Surg; 2015 Oct; 41(10):2060-8. PubMed ID: 26703280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracameral ketorolac and phenylephrine effect on intraoperative pupil diameter and postoperative pain in cataract surgery.
    Donnenfeld ED; Whitaker JS; Jackson MA; Wittpenn J
    J Cataract Refract Surg; 2017 May; 43(5):597-605. PubMed ID: 28602319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracameral phenylephrine and ketorolac injection (OMS302) for maintenance of intraoperative pupil diameter and reduction of postoperative pain in intraocular lens replacement with phacoemulsification.
    Lindstrom RL; Loden JC; Walters TR; Dunn SH; Whitaker JS; Kim T; Demopulos GA; Tjia K
    Clin Ophthalmol; 2014; 8():1735-44. PubMed ID: 25228791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain control and reduction of opioid use associated with intracameral phenylephrine1.0%-ketorolac 0.3% administered during cataract surgery.
    Donnenfeld ED; Mychajlyszyn D; Mychajlyszyn A; Stein R
    J Cataract Refract Surg; 2022 Jul; 48(7):759-764. PubMed ID: 34860481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intracameral phenylephrine 1.0%-ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery.
    Visco DM; Bedi R
    J Cataract Refract Surg; 2020 Jun; 46(6):867-872. PubMed ID: 32541407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
    Stewart R; Grosserode R; Cheetham JK; Rosenthal A
    Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phenylephrine 1.0%-ketorolac 0.3% injection on tamsulosin-associated intraoperative floppy-iris syndrome.
    Silverstein SM; Rana VK; Stephens R; Segars L; Pankratz J; Rana S; Juzych MS; Nariman N
    J Cataract Refract Surg; 2018 Sep; 44(9):1103-1108. PubMed ID: 30078537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intracameral phenylephrine-ketorolac irrigation for miosis prevention in femtosecond laser-assisted cataract surgery: Reduction in surgical time and iris manipulation.
    Walter K; Delwadia N; Coben J
    J Cataract Refract Surg; 2019 Apr; 45(4):465-469. PubMed ID: 30661968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual outcomes, efficacy, and surgical complications associated with intracameral phenylephrine 1.0%/ketorolac 0.3% administered during cataract surgery.
    Rosenberg ED; Nattis AS; Alevi D; Chu RL; Bacotti J; LoPinto RJ; D'Aversa G; Donnenfeld ED
    Clin Ophthalmol; 2018; 12():21-28. PubMed ID: 29317798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient considerations in cataract surgery - the role of combined therapy using phenylephrine and ketorolac.
    Gonzalez-Salinas R; Guarnieri A; Guirao Navarro MC; Saenz-de-Viteri M
    Patient Prefer Adherence; 2016; 10():1795-1801. PubMed ID: 27695298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world opioid prescribing after cataract surgery among patients who received intracameral phenylephrine and ketorolac 1.0%/0.3.
    Jackson K; Wisely CE; Davis BM; Griffin B; Kim T
    Curr Med Res Opin; 2020 Dec; 36(12):2047-2052. PubMed ID: 33030383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial.
    Kim SJ; Lo WR; Hubbard GB; Srivastava SK; Denny JP; Martin DF; Yan J; Bergstrom CS; Cribbs BE; Schwent BJ; Aaberg TM
    Arch Ophthalmol; 2008 Sep; 126(9):1203-8. PubMed ID: 18779478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Short-term Preoperative Topical Ketorolac on Pupil Diameter in Eyes Undergoing Femtosecond Laser-Assisted Capsulotomy.
    Diakonis VF; Kontadakis GA; Anagnostopoulos AG; Yesilirmak N; Waren DP; Cabot F; Yoo SH; Donaldson KE
    J Refract Surg; 2017 Apr; 33(4):230-234. PubMed ID: 28407162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery.
    Lawuyi LE; Gurbaxani A
    Clin Ophthalmol; 2015; 9():1249-54. PubMed ID: 26203214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of intraoperative use of tropicamide 0.02%/phenylephrine0.31%/lidocaine1% intracameral combination during pediatric cataract surgery.
    Nucci P; Lembo A; Caputo R; Dellavalle A; Serafino M; Schiavetti I; Pichi F
    Int Ophthalmol; 2023 Mar; 43(3):989-995. PubMed ID: 36053475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intraoperative intracameral mydriasis in manual small incision cataract surgery - A randomized controlled trial.
    Ajay K; Saranya S; Sundaresh DD; Hithashree HR; Hemalatha BC; Krishnaswamy M; Shetty SB
    Indian J Ophthalmol; 2017 Jul; 65(7):584-588. PubMed ID: 28724815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketorolac use for postoperative pain management following lumbar decompression surgery: a prospective, randomized, double-blinded, placebo-controlled trial.
    Cassinelli EH; Dean CL; Garcia RM; Furey CG; Bohlman HH
    Spine (Phila Pa 1976); 2008 May; 33(12):1313-7. PubMed ID: 18496342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Trattler W; McDonald M
    Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phenylephrine/ketorolac on iris fixation ring use and surgical times in patients at risk of intraoperative miosis.
    Visco D
    Clin Ophthalmol; 2018; 12():301-305. PubMed ID: 29440873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.